Christophe R. Jean's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 7,037 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 7,037 | 7,037 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 4,712 | 4,712 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 4,000 | 7,000 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 4,000 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 3,000 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 4,000 | 4,000 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |